Nov 05, 2026
Tarsus to Participate in Upcoming Investor Conferences
Nov 03, 2026
Tarsus Reports Third Quarter 2026 Financial Results
Oct 29, 2026
Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
Oct 28, 2026
Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer
Sep 29, 2026
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
Sep 04, 2026
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care
Sep 01, 2026
Tarsus to Participate in Upcoming Investor Conferences
Aug 06, 2026
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
Aug 06, 2026
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
Aug 06, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
Displaying 1 - 10 of 24